Novo Nordisk and Lyfebulb announce new diabetes collaboration

Novo Nordisk has announced a new partnership with Lyfebulb to develop new solutions for people with diabetes.

The partnership will focus on patient entrepreneurs developing innovative ideas and concepts for improved management of diabetes through the use of consumer and medical devices or healthcare information technology.

Their work will aim to link entrepreneurs with senior device researchers from Novo Nordisk, allowing promising efforts and ideas to be highlighted in a way that provides professional discussion, direction and inspiration.

Lyfebulb believes this project will help to expand the scope of its Entrepreneur Circle, which provides exposure to patient entrepreneurs who seek to truly transform their businesses.

Kenneth Stromdahl, senior vice-president for Novo Nordisk device research and development, said: "Having the patient at the centre of everything we do directs us in our daily work. My team and I look forward to the unique opportunity to learn from and be inspired by the patient entrepreneurs."

This comes after the firm recently partnered with Aarhus University's science and technology faculty on a scholarship programme to strengthen protein technology research and development.